Estradiol inhibits NLRP3 inflammasome in fibroblast-like synoviocytes activated by lipopolysaccharide and adenosine triphosphate
International Journal of Rheumatic Diseases Nov 08, 2017
Shi J, et al. - The goal of this investigation was to find out if nucleotide binding domain and leucine-rich repeat pyrin 3 domain (NLRP3) inflammasome can be triggered by lipopolysaccharides (LPS) and adenosine triphos adenine (ATP), which are positively related with knee osteoarthritis (OA) severity in joint-spaces, in human fibroblast-like synoviocytes (FLS). Researchers also determined if estrogen would inhibit the activation of NLRP3 inflammasome. Findings indicated that via NLRP3 inflammasome, knee OA may be promoted by the increased LPS and ATP in joint-space. Data also highlighted a possible protective impact of estradiol (E2) via inhibition of activation of NLRP3 inflammasome in FLS.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries